Formulation: Advances in formulation development & manufacture for solid dosage, injectables, liquids & specialty dosage forms - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Formulation
Oral tablets & capsules. Solutions, suspensions, injectables, as well as topical ointments, gels & solutions. Lyophilization (freeze drying), spray drying, hot-melt extrusion & nanocrystal technology.

Advances in Controlled-Release Drug Delivery

June 2, 2014

Pharmaceutical Technology

Industry experts share their perspectives on key advances in controlled-release drug delivery and future innovations in this arena.

FDA Issues Guidance on Expedited Programs for Serious Conditions

May 30, 2014

FDA finalizes guidance on expedited programs for new drug approvals for treatment of serious and life-threatening conditions.

Extractables and Leachables Testing

May 2, 2014

Pharmaceutical Technology

Industry experts discuss how extractables and leachables studies are designed using a risk-based approach.

Freeze Drying Protein Formulations

May 2, 2014

Pharmaceutical Technology

Common challenges and key considerations when developing a freeze-drying cycle for protein pharmaceuticals.

Achieving Zero-Order Release Kinetics Using Multi-Step Diffusion-Based Drug Delivery

May 2, 2014

Pharmaceutical Technology

Zero-order release of a freely water-soluble active drug can be obtained using release-controlling polymers.

Drug Encapsulation for Patient-Centric Dosing

April 2, 2014

Pharmaceutical Technology

Encapsulation technologies for solubility/bioavailability enhancement, controlled release, and formulation of drug combinations and patient-friendly dosage forms.

Tackling challenges in the development of fixed-dose combinations

April 2, 2014

Pharmaceutical Technology

Anil Kane from Patheon spoke to Pharmaceutical Technology about the challenges in the development of FDCs and discussed how to integrate quality-by-design (QbD) in the manufacturing process of FDCs.

Navigating the Regulatory Landscape of Combination Products

April 2, 2014

Pharmaceutical Technology

Mark D. Kramer talks about combination products from a regulatory perspective and explains the implications of FDA's final rule on current GMP requirements for combination products.

A Survey of Postapproval CMC Changes to Generic Drugs

March 2, 2014

Pharmaceutical Technology

A survey on postapproval CMC changes was conducted to better understand reporting categories, nature and risks, and review outcomes.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Click here